JP2023022566A - Transparent skin cleansing composition - Google Patents
Transparent skin cleansing composition Download PDFInfo
- Publication number
- JP2023022566A JP2023022566A JP2021127502A JP2021127502A JP2023022566A JP 2023022566 A JP2023022566 A JP 2023022566A JP 2021127502 A JP2021127502 A JP 2021127502A JP 2021127502 A JP2021127502 A JP 2021127502A JP 2023022566 A JP2023022566 A JP 2023022566A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- transparent skin
- acid
- amphoteric surfactant
- component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 38
- -1 fatty acid salt Chemical class 0.000 claims abstract description 27
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 22
- 239000000194 fatty acid Substances 0.000 claims abstract description 22
- 229930195729 fatty acid Natural products 0.000 claims abstract description 22
- 239000002280 amphoteric surfactant Substances 0.000 claims abstract description 15
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims abstract description 9
- 150000005215 alkyl ethers Chemical class 0.000 claims abstract description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims abstract 4
- 229960002449 glycine Drugs 0.000 claims abstract 2
- 235000013905 glycine and its sodium salt Nutrition 0.000 claims abstract 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 24
- 229960003237 betaine Drugs 0.000 claims description 12
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 claims description 4
- 229940117986 sulfobetaine Drugs 0.000 claims description 4
- 239000006260 foam Substances 0.000 abstract description 29
- 210000002374 sebum Anatomy 0.000 abstract description 18
- 230000000694 effects Effects 0.000 abstract description 16
- 238000004140 cleaning Methods 0.000 abstract 1
- 239000000284 extract Substances 0.000 description 67
- 210000003491 skin Anatomy 0.000 description 29
- 150000004665 fatty acids Chemical class 0.000 description 17
- 238000005187 foaming Methods 0.000 description 14
- 239000003240 coconut oil Substances 0.000 description 10
- 235000019864 coconut oil Nutrition 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 239000002453 shampoo Substances 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 6
- 241001474374 Blennius Species 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 239000003945 anionic surfactant Substances 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-M Aminoacetate Chemical compound NCC([O-])=O DHMQDGOQFOQNFH-UHFFFAOYSA-M 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
- 239000000419 plant extract Substances 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- NLMKTBGFQGKQEV-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hexadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO NLMKTBGFQGKQEV-UHFFFAOYSA-N 0.000 description 3
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 2
- KAKVFSYQVNHFBS-UHFFFAOYSA-N (5-hydroxycyclopenten-1-yl)-phenylmethanone Chemical compound OC1CCC=C1C(=O)C1=CC=CC=C1 KAKVFSYQVNHFBS-UHFFFAOYSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- PXGZQGDTEZPERC-UHFFFAOYSA-N 1,4-cyclohexanedicarboxylic acid Chemical compound OC(=O)C1CCC(C(O)=O)CC1 PXGZQGDTEZPERC-UHFFFAOYSA-N 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- KWVPFECTOKLOBL-KTKRTIGZSA-N 2-[(z)-octadec-9-enoxy]ethanol Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCO KWVPFECTOKLOBL-KTKRTIGZSA-N 0.000 description 2
- ICIDSZQHPUZUHC-UHFFFAOYSA-N 2-octadecoxyethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCO ICIDSZQHPUZUHC-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- DDGPBVIAYDDWDH-UHFFFAOYSA-N 3-[dodecyl(dimethyl)azaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC(O)CS([O-])(=O)=O DDGPBVIAYDDWDH-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 2
- 240000006891 Artemisia vulgaris Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 241000195955 Equisetum hyemale Species 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- FWKQNCXZGNBPFD-UHFFFAOYSA-N Guaiazulene Chemical compound CC(C)C1=CC=C(C)C2=CC=C(C)C2=C1 FWKQNCXZGNBPFD-UHFFFAOYSA-N 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 244000170916 Paeonia officinalis Species 0.000 description 2
- 235000006484 Paeonia officinalis Nutrition 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- 241000207929 Scutellaria Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 235000006468 Thea sinensis Nutrition 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 229920006322 acrylamide copolymer Polymers 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- 229940091509 beheneth-20 Drugs 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- MRUAUOIMASANKQ-UHFFFAOYSA-O carboxymethyl-[3-(dodecanoylamino)propyl]-dimethylazanium Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(O)=O MRUAUOIMASANKQ-UHFFFAOYSA-O 0.000 description 2
- 229940008396 carrot extract Drugs 0.000 description 2
- 229940106189 ceramide Drugs 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 239000012459 cleaning agent Substances 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000002826 coolant Substances 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- GQOKIYDTHHZSCJ-UHFFFAOYSA-M dimethyl-bis(prop-2-enyl)azanium;chloride Chemical compound [Cl-].C=CC[N+](C)(C)CC=C GQOKIYDTHHZSCJ-UHFFFAOYSA-M 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 229930195712 glutamate Natural products 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 235000020717 hawthorn extract Nutrition 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 229940075468 lauramidopropyl betaine Drugs 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- DVEKCXOJTLDBFE-UHFFFAOYSA-N n-dodecyl-n,n-dimethylglycinate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC([O-])=O DVEKCXOJTLDBFE-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 235000021313 oleic acid Nutrition 0.000 description 2
- 229940095127 oleth-20 Drugs 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- PYJBVGYZXWPIKK-UHFFFAOYSA-M potassium;tetradecanoate Chemical compound [K+].CCCCCCCCCCCCCC([O-])=O PYJBVGYZXWPIKK-UHFFFAOYSA-M 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 229940114926 stearate Drugs 0.000 description 2
- 229940100459 steareth-20 Drugs 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 229920003169 water-soluble polymer Polymers 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- REHQLKUNRPCYEW-UHFFFAOYSA-N 1-methylcyclohexane-1-carboxylic acid Chemical compound OC(=O)C1(C)CCCCC1 REHQLKUNRPCYEW-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- BKUWWVKLLKXDJK-UHFFFAOYSA-N 2-(dimethylamino)icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCC(N(C)C)C(O)=O BKUWWVKLLKXDJK-UHFFFAOYSA-N 0.000 description 1
- UYZIMGIUGBXMOC-UHFFFAOYSA-N 2-(octadecanoylamino)propanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)NC(C)C(O)=O UYZIMGIUGBXMOC-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- YPDCDBRKWQYBPV-UHFFFAOYSA-N 2-[2-(dodecanoylamino)ethyl-(2-hydroxyethyl)amino]acetic acid;sodium Chemical compound [Na].CCCCCCCCCCCC(=O)NCCN(CCO)CC(O)=O YPDCDBRKWQYBPV-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- LIFHMKCDDVTICL-UHFFFAOYSA-N 6-(chloromethyl)phenanthridine Chemical compound C1=CC=C2C(CCl)=NC3=CC=CC=C3C2=C1 LIFHMKCDDVTICL-UHFFFAOYSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- 240000000073 Achillea millefolium Species 0.000 description 1
- 235000007754 Achillea millefolium Nutrition 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 244000298715 Actinidia chinensis Species 0.000 description 1
- 235000009434 Actinidia chinensis Nutrition 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 241001105098 Angelica keiskei Species 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 208000035985 Body Odor Diseases 0.000 description 1
- 244000056139 Brassica cretica Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 241000951471 Citrus junos Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241000212948 Cnidium Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- JDRSMPFHFNXQRB-CMTNHCDUSA-N Decyl beta-D-threo-hexopyranoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)C(O)[C@H](O)C1O JDRSMPFHFNXQRB-CMTNHCDUSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- ILKBHIBYKSHTKQ-UHFFFAOYSA-N Diisopropylamine dichloroacetate Chemical compound OC(=O)C(Cl)Cl.CC(C)NC(C)C ILKBHIBYKSHTKQ-UHFFFAOYSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 244000111489 Gardenia augusta Species 0.000 description 1
- 239000006000 Garlic extract Substances 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- 239000009141 Houttuynia cordata plant extract Substances 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 241000546188 Hypericum Species 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 229920002884 Laureth 4 Polymers 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 241001648859 Lilium candidum Species 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 235000014435 Mentha Nutrition 0.000 description 1
- 241001072983 Mentha Species 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 241000183666 Nepsera aquatica Species 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 241000972673 Phellodendron amurense Species 0.000 description 1
- 108010020346 Polyglutamic Acid Proteins 0.000 description 1
- NKSOSPOXQKNIKJ-CLFAGFIQSA-N Polyoxyethylene dioleate Polymers CCCCCCCC\C=C/CCCCCCCC(=O)OCCOC(=O)CCCCCCC\C=C/CCCCCCCC NKSOSPOXQKNIKJ-CLFAGFIQSA-N 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 241000245165 Rhododendron ponticum Species 0.000 description 1
- 239000009724 Salvia extract Substances 0.000 description 1
- 244000151637 Sambucus canadensis Species 0.000 description 1
- 235000018735 Sambucus canadensis Nutrition 0.000 description 1
- 240000003946 Saponaria officinalis Species 0.000 description 1
- 241000543810 Sasa veitchii Species 0.000 description 1
- 241001647091 Saxifraga granulata Species 0.000 description 1
- 240000003377 Shepherdia canadensis Species 0.000 description 1
- 235000018324 Shepherdia canadensis Nutrition 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010040904 Skin odour abnormal Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000004164 Wax ester Substances 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- AQKOHYMKBUOXEB-RYNSOKOISA-N [(2R)-2-[(2R,3R,4S)-4-hydroxy-3-(16-methylheptadecanoyloxy)oxolan-2-yl]-2-(16-methylheptadecanoyloxy)ethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCC(C)C)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCCCCCCCCCC(C)C AQKOHYMKBUOXEB-RYNSOKOISA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 229920000800 acrylic rubber Polymers 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 150000001346 alkyl aryl ethers Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- BTBJBAZGXNKLQC-UHFFFAOYSA-N ammonium lauryl sulfate Chemical compound [NH4+].CCCCCCCCCCCCOS([O-])(=O)=O BTBJBAZGXNKLQC-UHFFFAOYSA-N 0.000 description 1
- 229940063953 ammonium lauryl sulfate Drugs 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000019206 astragalus extract Nutrition 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229940050390 benzoate Drugs 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 150000001277 beta hydroxy acids Chemical class 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 235000007123 blue elder Nutrition 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- 150000001841 cholesterols Chemical class 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 229940001468 citrate Drugs 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 229940073499 decyl glucoside Drugs 0.000 description 1
- 238000007257 deesterification reaction Methods 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 229940084113 diisopropylamine dichloroacetate Drugs 0.000 description 1
- SMVRDGHCVNAOIN-UHFFFAOYSA-L disodium;1-dodecoxydodecane;sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC SMVRDGHCVNAOIN-UHFFFAOYSA-L 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- QGVQVNIIRBPOAM-UHFFFAOYSA-N dodecyl naphthalene-1-sulfonate;sodium Chemical compound [Na].C1=CC=C2C(S(=O)(=O)OCCCCCCCCCCCC)=CC=CC2=C1 QGVQVNIIRBPOAM-UHFFFAOYSA-N 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 210000003278 egg shell Anatomy 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 235000007124 elderberry Nutrition 0.000 description 1
- 235000008995 european elder Nutrition 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 229940072117 fennel extract Drugs 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- 235000020706 garlic extract Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000020686 ginkgo biloba extract Nutrition 0.000 description 1
- 229940068052 ginkgo biloba extract Drugs 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 229940065115 grapefruit extract Drugs 0.000 description 1
- 229960002350 guaiazulen Drugs 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 235000020721 horse chestnut extract Nutrition 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000000077 insect repellent Substances 0.000 description 1
- 229940001447 lactate Drugs 0.000 description 1
- 229940062711 laureth-9 Drugs 0.000 description 1
- 229940071085 lauroyl glutamate Drugs 0.000 description 1
- PYIDGJJWBIBVIA-UYTYNIKBSA-N lauryl glucoside Chemical compound CCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PYIDGJJWBIBVIA-UYTYNIKBSA-N 0.000 description 1
- 229940048848 lauryl glucoside Drugs 0.000 description 1
- 229940083980 lavender extract Drugs 0.000 description 1
- 235000020723 lavender extract Nutrition 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229940105902 mint extract Drugs 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- 125000001419 myristoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- SNMVRZFUUCLYTO-UHFFFAOYSA-N n-propyl chloride Chemical compound CCCCl SNMVRZFUUCLYTO-UHFFFAOYSA-N 0.000 description 1
- 235000013557 nattō Nutrition 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 239000008041 oiling agent Substances 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 238000006864 oxidative decomposition reaction Methods 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 238000001139 pH measurement Methods 0.000 description 1
- 235000020737 peppermint extract Nutrition 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 229940067631 phospholipid Drugs 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- ONJQDTZCDSESIW-UHFFFAOYSA-N polidocanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO ONJQDTZCDSESIW-UHFFFAOYSA-N 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 229940114930 potassium stearate Drugs 0.000 description 1
- MQOCIYICOGDBSG-UHFFFAOYSA-M potassium;hexadecanoate Chemical compound [K+].CCCCCCCCCCCCCCCC([O-])=O MQOCIYICOGDBSG-UHFFFAOYSA-M 0.000 description 1
- ANBFRLKBEIFNQU-UHFFFAOYSA-M potassium;octadecanoate Chemical compound [K+].CCCCCCCCCCCCCCCCCC([O-])=O ANBFRLKBEIFNQU-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 150000004609 retinol derivatives Chemical class 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 229940112950 sage extract Drugs 0.000 description 1
- 235000020752 sage extract Nutrition 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 229940079991 sapindus trifoliatus fruit extract Drugs 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 229940078455 sodium lauroyl aspartate Drugs 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- IWIUXJGIDSGWDN-UQKRIMTDSA-M sodium;(2s)-2-(dodecanoylamino)pentanedioate;hydron Chemical compound [Na+].CCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC(O)=O IWIUXJGIDSGWDN-UQKRIMTDSA-M 0.000 description 1
- LFUXMTKAILZVTA-ZOWNYOTGSA-M sodium;(2s)-2-(dodecanoylamino)propanoate Chemical compound [Na+].CCCCCCCCCCCC(=O)N[C@@H](C)C([O-])=O LFUXMTKAILZVTA-ZOWNYOTGSA-M 0.000 description 1
- IEXXLSKKBWIDAC-ZOWNYOTGSA-M sodium;(3s)-3-(dodecanoylamino)-4-hydroxy-4-oxobutanoate Chemical compound [Na+].CCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CC(O)=O IEXXLSKKBWIDAC-ZOWNYOTGSA-M 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- QKJPFZCCZMBRFB-UHFFFAOYSA-M sodium;3-aminopropanoate Chemical compound [Na+].NCCC([O-])=O QKJPFZCCZMBRFB-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 235000020712 soy bean extract Nutrition 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 229940086735 succinate Drugs 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 229940057070 sugarcane extract Drugs 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 229940092665 tea leaf extract Drugs 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 239000001430 tilia cordata extract Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 108010021724 tonin Proteins 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003712 vitamin E derivatives Chemical class 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 235000019386 wax ester Nutrition 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000003357 wound healing promoting agent Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Abstract
Description
本発明は、透明皮膚洗浄剤組成物に関し、詳しくは、泡立ち、泡質(クリーミィ性)が良好であり、優れた皮脂汚れ洗浄効果を有し、すすぎ時のさっぱり感に優れ、低温安定性にも優れた透明皮膚洗浄剤組成物に関する。 TECHNICAL FIELD The present invention relates to a transparent skin cleanser composition, and more particularly, it has good foaming and foam quality (creaminess), has an excellent sebum stain cleansing effect, has an excellent refreshing feeling during rinsing, and has low temperature stability. also relates to an excellent transparent skin cleanser composition.
近年、女性のみならず男性においても、汗や皮脂、体臭に対するケア意識の高まりと共に、皮膚洗浄剤の市場が拡大しており、ボディソープ、クレンジング、洗顔料などの皮膚洗浄剤には、皮膚に付着した埃や汚れを除去するだけでなく、顔面、体などの皮脂汚れまでをも除去する効果が期待されている。これまでの皮膚洗浄剤には、皮脂汚れを除去するために、皮脂との溶解性の観点、並びに使用感の観点から、種々の界面活性剤が用いられている。 In recent years, not only women but also men have become more aware of how to care for sweat, sebum, and body odor, and the market for skin cleansers is expanding. It is expected to have the effect of not only removing dust and dirt adhering to it, but also removing even sebum stains on the face and body. Various surfactants have been used in conventional skin cleansers in order to remove sebum stains from the viewpoint of solubility with sebum and the viewpoint of feeling during use.
具体的には、アニオン性界面活性剤とカチオン性高分子と油剤とを含有する皮膚洗浄剤組成物(特許文献1を参照)、陰イオン性界面活性剤と非イオン性界面活性剤及び両性界面活性剤を含有する洗浄剤組成物(特許文献2を参照)、N-アシルアミノ酸系アニオン界面活性剤と両性界面活性剤とポリオキシエチレンアルキルエーテル硫酸塩とを含有する液体皮膚洗浄剤組成物(特許文献3を参照)などが提案されている。 Specifically, a skin cleanser composition containing an anionic surfactant, a cationic polymer and an oil (see Patent Document 1), an anionic surfactant, a nonionic surfactant and an amphoteric surface A cleansing composition containing an active agent (see Patent Document 2), a liquid skin cleansing composition containing an N-acylamino acid anionic surfactant, an amphoteric surfactant and a polyoxyethylene alkyl ether sulfate ( See Patent Document 3) and the like have been proposed.
しかしながら、特許文献1~3に開示の洗浄剤は、泡立ち、泡質(クリーミィ性)の低下やすすぎ時のぬるつきを生じさせる等の欠点があった。 However, the cleaning agents disclosed in Patent Documents 1 to 3 have drawbacks such as foaming, deterioration of foam quality (creaminess), and sliminess during rinsing.
本発明は上記事情に鑑みてなされたもので、その目的は、泡立ち、泡質(クリーミィ性)が良好であり、優れた皮脂汚れ洗浄効果を有し、すすぎ時のさっぱり感に優れ、低温安定性にも優れた透明皮膚洗浄剤組成物を提供することにある。 The present invention has been made in view of the above circumstances, and its purpose is to provide good foaming and foam quality (creaminess), excellent sebum stain cleansing effect, excellent refreshing feeling during rinsing, and low temperature stability. To provide a transparent skin cleanser composition which is also excellent in properties.
発明者は上記課題に対して鋭意検討した結果、pHが9~11であり、高級脂肪酸塩と、HLB値が13~18であるポリオキシエチレンアルキルエーテルと、アミノ酢酸ベタイン型両性界面活性剤又はスルホベタイン型両性界面活性剤を組み合わせることにより、泡立ち、泡質(クリーミィ性)が良好であり、優れた皮脂汚れ洗浄効果を有し、すすぎ時のさっぱり感に優れた透明皮膚洗浄剤組成物が得られることを見出し、本発明を完成した。 As a result of intensive studies on the above problems, the inventors have found that a higher fatty acid salt having a pH of 9 to 11, a polyoxyethylene alkyl ether having an HLB value of 13 to 18, a betaine aminoacetate type amphoteric surfactant or By combining a sulfobetaine-type amphoteric surfactant, a transparent skin cleanser composition with good foaming and foam quality (creaminess), an excellent sebum stain cleansing effect, and an excellent refreshing feeling during rinsing can be obtained. The present invention was completed after discovering that it can be obtained.
すなわち、本発明は、(A)高級脂肪酸塩、(B)HLB値が13~18であるポリオキシエチレンアルキルエーテル、(C)アミノ酢酸ベタイン型両性界面活性剤又はスルホベタイン型両性界面活性剤を含有し、pHが9~11であることを特徴とする透明皮膚洗浄剤組成物である。 That is, the present invention provides (A) a higher fatty acid salt, (B) a polyoxyethylene alkyl ether having an HLB value of 13 to 18, and (C) a betaine aminoacetate type amphoteric surfactant or a sulfobetaine type amphoteric surfactant. and having a pH of 9-11.
好ましくは、前記(B)成分が全体質量中0.05~5%である透明皮膚洗浄剤組成物である。 Preferably, the transparent skin cleanser composition contains 0.05 to 5% of the component (B) in the total mass.
本発明によれば、泡立ち、泡質(クリーミィ性)が良好であり、優れた皮脂汚れ洗浄効果を有し、すすぎ時のさっぱり感に優れ、低温安定性にも優れた透明皮膚洗浄剤組成物を提供することができる。 According to the present invention, a transparent skin cleanser composition which foams well and has good foam quality (creaminess), has an excellent sebum stain cleansing effect, has an excellent refreshing feeling during rinsing, and has excellent low-temperature stability. can be provided.
以下、本発明の透明皮膚洗浄剤組成物について詳細に説明する。 The transparent skin cleanser composition of the present invention will be described in detail below.
[洗浄料]
本発明の透明皮膚洗浄剤は、例えば、ボディソープ、洗顔フォーム、ハンドソープ等に用いることができる。
[Cleaning agent]
The transparent skin cleanser of the present invention can be used, for example, in body soap, facial cleansing foam, hand soap and the like.
透明皮膚洗浄剤の剤型は、公知の剤型の中から、その用途や使用目的等に応じて任意に選択することができる。例えば、液状、泡状、ゲル状等とすることができる。 The dosage form of the transparent skin cleanser can be arbitrarily selected from known dosage forms according to its use, purpose of use, and the like. For example, it can be liquid, foam, gel, or the like.
<(A)成分>
本発明の透明皮膚洗浄剤組成物で用いられる(A)成分は、高級級脂肪酸塩である。当該成分は、泡立ち、泡質(クリーミー性)、すすぎ時のさっぱり感に寄与する成分として加えられる。
<(A) Component>
The (A) component used in the transparent skin cleanser composition of the present invention is a higher fatty acid salt. This component is added as a component that contributes to foaming, foam quality (creaminess), and refreshing feeling during rinsing.
(A)成分として、例えば、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、オレイン酸、ベヘン酸等の炭素数12~22の高級脂肪酸;オリーブ油、綿実油等の植物性油脂;魚油、牛脂等の動物性油脂等が挙げられ、これらは、それぞれ1種単独で、又は二種以上を適宜組合せて用いることができる。 Component (A) includes, for example, higher fatty acids having 12 to 22 carbon atoms such as lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid and behenic acid; vegetable oils such as olive oil and cottonseed oil; Animal oils and fats, etc., can be mentioned, and these can be used singly or in combination of two or more.
本発明においては、洗浄力および起泡力の観点から、炭素数12~22の高級脂肪酸を用いるのが好ましく、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸がより好ましく用いられる。 In the present invention, from the viewpoint of detergency and foaming power, higher fatty acids having 12 to 22 carbon atoms are preferably used, and lauric acid, myristic acid, palmitic acid and stearic acid are more preferably used.
(A)成分の塩としては、高級脂肪酸をアルカリ剤でケン化、又は中和した、アルカリ金属塩や有機アミン塩等が挙げられる。用いられるアルカリ剤としては、水酸化ナトリウム、水酸化カリウム、炭酸ナトリウム、炭酸カリウム等の無機アルカリ、モノエタノールアミン、ジエタノールアミン、トリエタノールアミン、トリメチルアミン、トリエチルアミン等の有機アルカリ等が挙げられる。 Salts of the component (A) include alkali metal salts and organic amine salts obtained by saponifying or neutralizing higher fatty acids with an alkaline agent. Examples of the alkali agent to be used include inorganic alkalis such as sodium hydroxide, potassium hydroxide, sodium carbonate and potassium carbonate, and organic alkalis such as monoethanolamine, diethanolamine, triethanolamine, trimethylamine and triethylamine.
本発明においては、起泡力の観点から、無機アルカリを用いることが好ましく、水酸化カリウムがより好ましく用いられる。 In the present invention, from the viewpoint of foaming power, it is preferable to use an inorganic alkali, and potassium hydroxide is more preferably used.
(A)成分の配合量は、全組成中1~30質量%(以下、単に「%」と記す。)が好ましく、より好ましくは3~25%である。配合量が1%以上であれば、泡立ち、泡質(クリーミー性)が良好であり、30%以下であれば低温での安定性が改善する傾向にある。 The blending amount of component (A) is preferably 1 to 30 mass % (hereinafter simply referred to as "%") in the total composition, more preferably 3 to 25%. When the blending amount is 1% or more, good foamability and foam quality (creaminess) are obtained, and when the blending amount is 30% or less, stability at low temperatures tends to be improved.
<成分(B)>
本発明の透明皮膚洗浄剤組成物で用いられる(B)成分は、HLB値が13~18であるポリオキシエチレンアルキルエーテルである。当該成分は、皮脂汚れ洗浄効果、低温安定性に寄与する成分として加えられる。(B)成分は、1種のみが用いられてもよく、2種以上が併用されてもよい。
<Component (B)>
The component (B) used in the transparent skin cleanser composition of the present invention is a polyoxyethylene alkyl ether having an HLB value of 13-18. This component is added as a component that contributes to sebum stain cleansing effect and low temperature stability. As for (B) component, only 1 type may be used and 2 or more types may be used together.
(B)成分は、HLB値が13~18 が好ましく、13~16 がより好ましい。HLB値が13以下であると皮脂汚れ洗浄効果、低温安定性が低下することがある、または18以上であると皮脂汚れ洗浄効果が低下することがある。 Component (B) preferably has an HLB value of 13 to 18, more preferably 13 to 16. If the HLB value is 13 or less, the sebum stain cleansing effect and low-temperature stability may decrease, and if it is 18 or more, the sebum stain cleansing effect may decrease.
(B)成分は、アルキル基の炭素数としては、保存安定性の点から、12~22 が好ましく、12~16 がより好ましい。また、エチレンオキサイドの平均付加モル
数としては、保存安定性の点から、2~60が好ましく、2 ~30 がより好ましい。
The number of carbon atoms in the alkyl group of component (B) is preferably 12 to 22, more preferably 12 to 16, from the viewpoint of storage stability. The average number of added moles of ethylene oxide is preferably 2 to 60, more preferably 2 to 30, from the viewpoint of storage stability.
(B)成分の市販品としては、「NIKKOL BL-9EX(ラウレスー9)」、「NIKKOL BC-10(セテスー10)」、「NIKKOL BC-15(セテスー15)」、「NIKKOL BC-23(セテスー23)」、「NIKKOL BB-20(べへネスー20)」、「NIKKOL BB-30(べへネスー30)」、「NIKKOL BO-15V(オレスー15)」、「NIKKOL BO-20V(オレスー20)」、「NIKKOL BS-20(ステアレスー20)」(以上、日光ケミカルズ社製)等が挙げられ、これらを好適に使用することができる。 Commercially available products of component (B) include "NIKKOL BL-9EX (Laureth-9)", "NIKKOL BC-10 (Seteth-10)", "NIKKOL BC-15 (Seteth-15)", and "NIKKOL BC-23 (Seteth-15)". 23)”, “NIKKOL BB-20”, “NIKKOL BB-30”, “NIKKOL BO-15V”, “NIKKOL BO-20V” ”, “NIKKOL BS-20” (manufactured by Nikko Chemicals Co., Ltd.) and the like, and these can be preferably used.
(B)成分の配合量は0.05~5%が好ましく、0.05~3%がより好ましい。配合0が0.05%以上であれば、皮脂汚れ洗浄効果、低温安定性が良好である。一方、5%以下であればすすぎ時のさっぱり感が良好になる。 The amount of component (B) is preferably 0.05 to 5%, more preferably 0.05 to 3%. When the content of 0 is 0.05% or more, the sebum stain cleansing effect and low temperature stability are good. On the other hand, if it is 5% or less, a refreshing feeling during rinsing is improved.
<成分(C)>
本発明の透明皮膚洗浄剤組成物で用いられる(C)成分は、アミノ酢酸ベタイン型両性界面活性剤又はスルホベタイン型両性界面活性剤である。当該成分は、泡質(クリーミィ性)、低温安定性に寄与する成分として加えられる。1種単独、又は2種以上を適宜組み合わせて用いることができる。
<Component (C)>
The component (C) used in the transparent skin cleanser composition of the present invention is a betaine aminoacetate type amphoteric surfactant or a sulfobetaine type amphoteric surfactant. This component is added as a component that contributes to foam quality (creaminess) and low-temperature stability. One type can be used alone, or two or more types can be used in appropriate combination.
(C)成分のアミノ酢酸ベタイン型両性界面活性剤としては、例えばラウリルジメチルアミノ酢酸ベタイン、ヤシ油アルキルジメチルアミノ酢酸ベタイン、ステアリルジメチルアミノ酢酸ベタイン等が挙げられる。市販のものとしては、例えば「ニッサンアノンBL」、「ニッサンアノンBF」(いずれも日油社製)、リカビオンA-100(新日本理科社製)等が挙げられる。 Examples of the betaine aminoacetate type amphoteric surfactant of component (C) include betaine lauryldimethylaminoacetate, betaine coconut oil alkyldimethylaminoacetate, betaine stearyldimethylaminoacetate and the like. Commercially available products include, for example, "Nissan Anon BL", "Nissan Anon BF" (both manufactured by NOF Corp.), Licavion A-100 (manufactured by Shin Nihon Rika Co., Ltd.), and the like.
(C)成分のスルホベタイン型両性界面活性剤としては、例えばヤシ油脂肪酸ジメチルスルホプロピルベタイン、ラウリルジメチルアミノヒドロキシスルホベタイン、ラウリルヒドロキシスルホベタイン等が挙げられる。市販のものとしては、例えば「アンヒトール20HD」(花王社製)、「アンホレックスLSB」(ミヨシ油脂社製)等が挙げられる。 Examples of the (C) component sulfobetaine type amphoteric surfactant include coconut oil fatty acid dimethylsulfopropylbetaine, lauryldimethylaminohydroxysulfobetaine, laurylhydroxysulfobetaine and the like. Examples of commercially available products include "Amphitol 20HD" (manufactured by Kao Corporation) and "Ampholex LSB" (manufactured by Miyoshi Yushi Co., Ltd.).
(C)成分の配合量は、0.1~8%が好ましく、0.5~5%がより好ましい。配合量が0.1%以上であれば、泡質(クリーミィ性)が良好で、低温安定性を改善することができる。一方、8%以下であればすすぎ時のさっぱり感が良好となる。 The amount of component (C) is preferably 0.1 to 8%, more preferably 0.5 to 5%. If the blending amount is 0.1% or more, the foam quality (creaminess) is good and the low temperature stability can be improved. On the other hand, if it is 8% or less, a refreshing feeling during rinsing will be good.
本発明の透明皮膚洗浄剤組成物は、上記成分(A)~(C)を必須成分として含み、pHが9~11に調整される。pHが9未満では、低温で結晶化することがあり、pHが11を超えると泡質(クリーミィ性)が低下し、皮膚刺激を起こす場合がある。尚、pHの測定はJIS K6220による。本発明の透明皮膚洗浄剤組成物には本発明の効果を損なわない範囲において、pH調整剤を適宜用いることができる。pH調整剤としては、乳酸塩、リンゴ酸塩、酒石酸塩、クエン酸塩、コハク酸塩、サリチル酸塩、安息香酸塩等の有機酸塩が好ましい。 The transparent skin cleanser composition of the present invention contains the above components (A) to (C) as essential components and is adjusted to pH 9-11. If the pH is less than 9, crystallization may occur at low temperatures, and if the pH exceeds 11, the foam quality (creaminess) may be reduced and skin irritation may occur. In addition, the measurement of pH is based on JISK6220. A pH adjuster can be appropriately used in the transparent skin cleanser composition of the present invention as long as it does not impair the effects of the present invention. Organic acid salts such as lactate, malate, tartrate, citrate, succinate, salicylate, and benzoate are preferred as pH adjusters.
<その他の成分>
本発明の透明皮膚洗浄剤組成物は、上述した成分の他に、本発明の目的を損なわない範囲で他の成分、例えば、アニオン界面活性剤、カチオン界面活性剤、両性界面活性剤、ノニオン界面活性剤、水溶性高分子化合物、生理活性成分、酸化防止剤、金属イオン封鎖剤、防腐剤、紫外線吸収剤、香料、保湿剤、塩類、溶媒、中和剤、昆虫忌避剤、酵素等の成分を適宜配合することができる。
<Other ingredients>
In addition to the components described above, the transparent skin cleanser composition of the present invention may contain other components, such as anionic surfactants, cationic surfactants, amphoteric surfactants, and nonionic surfactants, as long as the objects of the present invention are not impaired. Ingredients such as active agents, water-soluble polymer compounds, bioactive ingredients, antioxidants, sequestering agents, preservatives, UV absorbers, fragrances, moisturizers, salts, solvents, neutralizers, insect repellents, enzymes, etc. can be appropriately blended.
上記アニオン界面活性剤としては、特に限定されるものではないが、例えばN-ヤシ油脂肪酸アシルグリシンカリウム、N-ヤシ油脂肪酸アシルグリシンナトリウム、N-パーム核油脂肪酸アシルグリシンアンモニウム、N-ヤシ油脂肪酸アシルグルタミン酸カリウム、N-ヤシ油脂肪酸アシルグルタミン酸トリエタノールアミン、N-ラウロイルグルタミン酸ナトリウム、N-ラウロイルグルタミン酸トリエタノールアミン、N-ラウロイルアラニンナトリウム、N-ステアロイルアラニンナトリウム、ラウロイルアスパラギン酸ナトリウム、α-ラウロイルスルホン酸ナトリウム、ミリストイルアリルスルホン酸ナトリウム、ラウリルナフタレンスルホン酸ナトリウム、ラウリル硫酸トリエタノールアミン、ラウリル硫酸アンモニウム、ラウリルエーテル硫酸ナトリウム、ポリオキシエチレンラウリルエーテル硫酸ナトリウム、ポリオキシエチレンヤシ油脂肪酸アミドエーテル硫酸カリウム等が挙げられ、適宜一種又は二種以上選択して用いればよい。 Examples of the anionic surfactant include, but are not limited to, potassium N-coconut fatty acid acylglycinate, sodium N-coconut fatty acid acylglycinate, ammonium N-palm kernel fatty acid acylglycinate, and N-coconut oil. Potassium fatty acid acyl glutamate, triethanolamine N-coconut fatty acid acyl glutamate, sodium N-lauroyl glutamate, triethanolamine N-lauroyl glutamate, sodium N-lauroyl alanine, sodium N-stearoyl alanine, sodium lauroyl aspartate, α-lauroyl Sodium sulfonate, sodium myristoyl allyl sulfonate, sodium lauryl naphthalene sulfonate, triethanolamine lauryl sulfate, ammonium lauryl sulfate, sodium lauryl ether sulfate, sodium polyoxyethylene lauryl ether sulfate, potassium polyoxyethylene coconut oil fatty acid amide ether sulfate, etc. One or two or more may be appropriately selected and used.
上記両性界面活性剤としては、特に限定されるものではないが、例えばラウリン酸アミドプロピルベタイン、ヤシ油脂肪酸アミドプロピルベタイン、2-アルキル-N-カルボキシメチル-N-ヒドロキシエチルイミダゾリニウムベタイン、β-アミノプロピオン酸ナトリウム、N-ラウロイル-N’-カルボキシメチル-N’-ヒドロキシエチルエチレンジアミンナトリウム等が挙げられ、適宜一種又は二種以上選択して用いればよい。 Examples of the amphoteric surfactant include, but are not limited to, lauramidopropyl betaine, coconut oil fatty acid amidopropyl betaine, 2-alkyl-N-carboxymethyl-N-hydroxyethylimidazolinium betaine, β -Aminopropionate sodium, N-lauroyl-N'-carboxymethyl-N'-hydroxyethylethylenediamine sodium, etc., and one or more of them may be appropriately selected and used.
上記ノニオン界面活性剤としては、特に限定されるものではないが、例えばモノステアリン酸ソルビタン、トリイソステアリン酸ポリオキシエチレンソルビタン、デシルグルコシド、ラウリルグルコシド、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンモノイソステアレート、ポリオキシエチレンジオレイン酸グリセリル、ヤシ油脂肪酸ジエタノールアミド、ヤシ油脂肪酸モノエタノールアミド、ヤシ油脂肪酸N-メチルエタノールアミド、ポリオキシエチレンポリオキシプロピレングリコール、モノラウリン酸ポリエチレングリコール、ポリグリセリルモノアルキルエーテル等が挙げられ、適宜一種又は二種以上選択して用いればよい。 Examples of the nonionic surfactant include, but are not limited to, sorbitan monostearate, polyoxyethylene sorbitan triisostearate, decyl glucoside, lauryl glucoside, polyoxyethylene hydrogenated castor oil, polyoxyethylene monoisostea. polyoxyethylene dioleate glyceryl, coconut oil fatty acid diethanolamide, coconut oil fatty acid monoethanolamide, coconut oil fatty acid N-methylethanolamide, polyoxyethylene polyoxypropylene glycol, polyethylene glycol monolaurate, polyglyceryl monoalkyl ether, etc. and may be used by appropriately selecting one or more.
上記水溶性高分子としては、特に限定されるものではないが、例えばヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、ポリエチレングリコール、高重合ポリエチレングリコール、ポリビニルアルコール、ポリグルタミン酸、カルボキシビニルポリマー、アクリル酸・メタクリル酸アルキル共重合体、アクリル酸アルキル共重合体、塩化O-[2-ヒドロキシ-3-(トリメチルアンモニオ)プロピル]ヒドロキシエチルセルロース、塩化O-[2-ヒドロキシ-3-(トリメチルアンモニオ)プロピル]グァーガム、塩化ジメチルジアリルアンモニウム・アクリルアミド共重合体、及びアクリルアミド・アクリル酸・塩化ジメチルジアリルアンモニウム共重合体等が挙げられ、適宜一種又は二種以上選択して用いればよい。 Examples of the water-soluble polymer include, but are not limited to, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropylmethyl cellulose, polyethylene glycol, highly polymerized polyethylene glycol, polyvinyl alcohol, polyglutamic acid, carboxyvinyl polymer, acrylic acid, Alkyl methacrylate copolymer, alkyl acrylate copolymer, O-[2-hydroxy-3-(trimethylammonio)propyl]hydroxyethyl cellulose chloride, O-[2-hydroxy-3-(trimethylammonio)propyl chloride ] guar gum, dimethyldiallylammonium chloride/acrylamide copolymer, acrylamide/acrylic acid/dimethyldiallylammonium chloride copolymer, and the like, and one or more of them may be appropriately selected and used.
上記生理活性成分としては、皮膚に塗布した場合に皮膚に何らかの生理活性を与える物質が挙げられる。例えば、抗炎症剤、老化防止剤、紫外線防御剤、ひきしめ剤、抗酸化剤、保湿剤、血行促進剤、抗菌剤、殺菌剤、乾燥剤、冷感剤、温感剤、ビタミン類、アミノ酸、創傷治癒促進剤、刺激緩和剤、鎮痛剤、細胞賦活剤、酵素成分等が挙げられる。上記生理活性成分は、天然系の植物抽出成分、海藻抽出成分、生薬成分や、化合物等が挙げら
れるが、これらの中でも、特に天然系の植物抽出成分、海藻抽出成分、生薬成分が安全性の点で好ましい。
Examples of the physiologically active ingredient include substances that impart some physiological activity to the skin when applied to the skin. For example, anti-inflammatory agents, anti-aging agents, UV protection agents, tightening agents, antioxidants, moisturizing agents, blood circulation promoting agents, antibacterial agents, bactericidal agents, drying agents, cooling agents, warming agents, vitamins, amino acids, Examples thereof include wound healing promoters, stimulant relievers, analgesics, cell activators, enzyme components, and the like. The physiologically active ingredients include natural plant extracts, seaweed extracts, herbal medicines, compounds, etc. Among these, natural plant extracts, seaweed extracts, and herbal medicines are particularly safe point is preferable.
上記天然系の植物抽出成分、海藻抽出成分、生薬成分の例としては、例えばアシタバエキス、アマチャエキス、アルテアエキス、アロエエキス、アンズエキス、イチョウエキス、ウイキョウエキス、ウーロン茶エキス、エイジツエキス、オウゴンエキス、オウバクエキス、オトギリソウエキス、オランダカラシエキス、オレンジエキス、海水乾燥物、海藻エキス、加水分解コムギ末、加水分解シルク、カモミラエキス、カロットエキス、カワラヨモギエキス、甘草エキス、カキョクエキス、キウイエキス、キューカンバーエキス、クチナシエキス、クマザサエキス、クララエキス、クルミエキス、グレープフルーツエキス、クロレラエキス、クワエキス、紅茶エキス、酵母エキス、コラーゲン、サルビアエキス、サボンソウエキス、サンザシエキス、ジオウエキス、シコンエキス、シソエキス、シナノキエキス、シャクヤクエキス、シラカバエキス、スギナエキス、セイヨウキズタエキス、セイヨウサンザシエキス、セイヨウニワトコエキス、セイヨウノコギリソウエキス、セイヨウハッカエキス、セージエキス、センキュウエキス、センブリエキス、ダイズエキス、タイソウエキス、タイムエキス、茶エキス、チョウジエキス、チンピエキス、トウキエキス、トウニンエキス、ドクダミエキス、トマトエキス、納豆エキス、ニンジンエキス、ニンニクエキス、ノバラエキス、蜂蜜、ハマメリスエキス、ヒキオコシエキス、ビサボロール、ビワエキス、ブクリョウエキス、プロポリス、ヘチマエキス、ペパーミントエキス、ボダイジュエキス、ホップエキス、マドンナリリー花エキス、マロニエエキス、ムクロジエキス、メリッサエキス、モモエキス、ユキノシタエキス、ユズエキス、ヨモギエキス、ラベンダーエキス、レモンエキス、レンゲソウエキス、ローズマリーエキス、ローヤルゼリーエキス等を挙げることができる。 Examples of the natural plant extract components, seaweed extract components, and crude drug components include Angelica keiskei leaf extract, Gomacha extract, Altea extract, Aloe extract, Apricot extract, Ginkgo biloba extract, Fennel extract, Oolong tea extract, Agitsu extract, Scutellaria root extract, Phellodendron bark extract, Hypericum extract, Dutch mustard extract, Orange extract, Dried seawater, Seaweed extract, Hydrolyzed wheat powder, Hydrolyzed silk, Chamomile extract, Carrot extract, Kawara mugwort extract, Licorice extract, Kakyoku extract, Kiwi extract, Cucumber extract, Gardenia extract, kumazasa extract, clara extract, walnut extract, grapefruit extract, chlorella extract, mulberry extract, black tea extract, yeast extract, collagen, salvia extract, soapwort extract, hawthorn extract, rhododendron extract, rhizome extract, perilla extract, linden extract, peony extract, Birch extract, horsetail extract, horsetail extract, hawthorn extract, elderberry extract, yarrow extract, mint extract, sage extract, cnidium extract, assembly extract, soybean extract, taisou extract, thyme extract, tea extract, clove extract, chimp extract , Touki extract, Tonin extract, Houttuynia cordata extract, Tomato extract, Natto extract, Carrot extract, Garlic extract, Novara extract, Honey, Hamamelis extract, Hikiokoshi extract, Bisabolol, Loquat extract, Bukuryou extract, Propolis, Loofah extract, Peppermint extract, Bodaiju extract, Hop extract, Madonna lily flower extract, horse chestnut extract, soapberry extract, melissa extract, peach extract, saxifrage extract, yuzu extract, mugwort extract, lavender extract, lemon extract, astragalus extract, rosemary extract, royal jelly extract and the like.
また、上記天然系の植物抽出成分、海藻抽出成分、生薬成分以外の成分としては、例えばデオキシリボ核酸、コラーゲン、エラスチン、キチン、キトサン、加水分解卵殻膜などの生体高分子、アミノ酸、乳酸ナトリウム、尿素、ピロリドンカルボン酸ナトリウム、ベタイン、ホエイなどの保湿成分、スフィンゴ脂質、セラミド、コレステロール、コレステロール誘導体、リン脂質などの油性成分、ε-アミノカプロン酸、グリチルリチン酸、β-グリチルレチン酸、塩化リゾチーム、グアイアズレン、ヒドロコルチゾン等の抗炎症剤、ビタミン類(A、B2、B6、C、D、E)、パントテン酸カルシウム、ビオチン、ニコチン酸アミド、ビタミンCエステル等のビタミン類、アラントイン、ジイソプロピルアミンジクロロアセテート、4-アミノメチルシクロヘキサンカルボン酸等の活性成分、トコフェロール、カロチノイド、フラボノイド、タンニン、リグナン、サポニン等の抗酸化剤、α-ヒドロキシ酸、β-ヒドロキシ酸などの細胞賦活剤、γ-オリザノール、ビタミンE誘導体などの血行促進剤、イソプロピルメチルフェノール、トリクロサン、ヒノキチオール、塩化ベンザルコニウム等の殺菌剤、l-メントール、ハッカ油等の冷感剤、レチノール、レチノール誘導体等の創傷治癒剤等が挙げられる。 Components other than the natural plant extract components, seaweed extract components, and crude drug components include, for example, deoxyribonucleic acid, collagen, elastin, chitin, chitosan, biopolymers such as hydrolyzed eggshell membranes, amino acids, sodium lactate, and urea. , sodium pyrrolidonecarboxylate, betaine, moisturizing ingredients such as whey, sphingolipids, ceramides, cholesterol, cholesterol derivatives, oily ingredients such as phospholipids, ε-aminocaproic acid, glycyrrhizic acid, β-glycyrrhetinic acid, lysozyme chloride, guaiazulene, hydrocortisone Anti-inflammatory agents such as vitamins (A, B2, B6, C, D, E), calcium pantothenate, biotin, nicotinamide, vitamins such as vitamin C ester, allantoin, diisopropylamine dichloroacetate, 4-amino Active ingredients such as methylcyclohexanecarboxylic acid, antioxidants such as tocopherol, carotenoids, flavonoids, tannins, lignans, and saponins, cell activators such as α-hydroxy acids and β-hydroxy acids, γ-oryzanol, vitamin E derivatives, etc. Blood circulation promoters, bactericides such as isopropylmethylphenol, triclosan, hinokitiol, and benzalkonium chloride, cooling agents such as l-menthol and mint oil, and wound healing agents such as retinol and retinol derivatives.
次に本発明について実施例をもって詳細に説明するが、本発明はこれにより限定されるものではない。実施例に先立ち、各実施例で採用した試験法、評価法を説明する。 EXAMPLES Next, the present invention will be described in detail with reference to Examples, but the present invention is not limited to these. Prior to Examples, test methods and evaluation methods employed in each Example will be described.
(1)起泡力試験(泡立ち)
1,000mL容器の攪拌機つき円筒形シリンダーに、実施例及び比較例の透明皮膚洗浄剤組成物の1%水溶液を80mL入れ、5,000rpmで30秒間攪拌した後の泡容積を測定した。また、評価の基準を次のように設定した。
◎:泡立ち極めて良好 泡容積500mL以上
○:泡立ち良好 泡容積400mL以上,500mL未満
△:泡立ち普通 泡容積300mL以上,400mL未満
×:泡立ち不良 泡容積300mL未満
(1) Foaming power test (foaming)
80 mL of 1% aqueous solutions of the transparent skin cleanser compositions of Examples and Comparative Examples were placed in a 1,000 mL cylindrical cylinder equipped with a stirrer, stirred at 5,000 rpm for 30 seconds, and then the foam volume was measured. Moreover, the criteria for evaluation were set as follows.
◎: Very good foaming, foam volume 500 mL or more ○: Good foaming, foam volume 400 mL or more, less than 500 mL △: Normal foaming, foam volume 300 mL or more, less than 400 mL ×: Poor foaming, foam volume less than 300 mL
(2)泡質、すすぎ時の感触試験法
20名の専門パネルにより、実施例及び比較例の透明皮膚洗浄剤組成物を使用し、使用時の泡質(クリーミィ性)、すすぎ時のさっぱり感の各項目について官能評価した。尚、評価基準は以下の通りである。
[使用時の泡質(クリーミィ性)]
◎:極めて良好 泡質(クリーミィ性)が良いと答えた被験者の数が16人以上
○:良好 泡質(クリーミィ性)が良いと答えた被験者の数が12~15人
△:やや悪い 泡質(クリーミィ性)が良いと答えた被験者の数が8~11人
×:悪い 泡質(クリーミィ性)が良いと答えた被験者の数が8人未満
[すすぎ時のさっぱり感]
◎:極めて良好 すすぎ時にさっぱり感があると答えた被験者の数が16人以上
○:良好 すすぎ時にさっぱり感があると答えた被験者の数が12~15人
△:やや悪い すすぎ時にさっぱり感があると答えた被験者の数が8~11人
×:悪い すすぎ時にさっぱり感があると答えた被験者の数が8人未満
(2) Foam quality and rinsing feel test method A panel of 20 experts tested the foam quality (creaminess) during use and the refreshing feeling during rinsing using the transparent skin cleanser compositions of Examples and Comparative Examples. Each item was sensory evaluated. In addition, the evaluation criteria are as follows.
[Foam quality at the time of use (creaminess)]
◎: Very good The number of subjects who answered that the foam quality (creamy property) was good was 16 or more ○: The number of subjects who answered that the foam quality (creamy property) was good 12 to 15 people The number of subjects who answered that the (creaminess) was good was 8 to 11 ×: Poor The number of subjects who answered that the foam quality (creaminess) was good was less than 8 [refreshing feeling during rinsing]
◎: 16 or more subjects answered that they felt refreshed after rinsing. ○: 12-15 subjects answered that they felt refreshed after rinsing. The number of subjects who answered 8 to 11 ×: Bad The number of subjects who answered that they felt refreshed when rinsing was less than 8
(3)低温安定性試験(外観評価)
実施例及び比較例の透明皮膚洗浄剤組成物をガラス瓶に充填し、5℃で1ヶ月静置したときの経時安定性について、下記に示す判断基準により評価を行った。判断基準は以下の通りである。
◎:外観が透明で析出物なし
○:ごく微かに濁っているが析出物なし
△:やや白濁し、析出物が少しある
×:析出物が多く認められる
(3) Low temperature stability test (appearance evaluation)
The transparent skin cleanser compositions of Examples and Comparative Examples were filled in glass bottles and allowed to stand at 5° C. for 1 month, and the stability over time was evaluated according to the criteria shown below. Judgment criteria are as follows.
◎: Appearance is transparent and no precipitate ○: Slightly cloudy but no precipitate △: Slightly cloudy with a little precipitate ×: Many precipitates are observed
(4)皮脂汚れ洗浄効果
皮膚に存在する脂質成分には、セラミド、コレステロールなどの角層の細胞間脂質由来の脂質と、トリグリセライド、ジグリセリド、モノグリセリド、遊離脂肪酸、スクワレン、ワックスエステルなどの皮脂腺由来の脂質がある。特にトリグリセライドは、皮膚常在菌の代謝などによりエステル分解して高級脂肪酸に変換され、その後、オレイン酸やパルミトレイル酸などの不飽和脂肪酸が、さらに酸化的分解反応によって臭気物質に変換される。
(4) Sebum cleansing effect Lipid components present in the skin include lipids derived from intercellular lipids of the stratum corneum, such as ceramide and cholesterol, and sebaceous gland-derived lipids such as triglycerides, diglycerides, monoglycerides, free fatty acids, squalene, and wax esters. there is lipid In particular, triglycerides are converted into higher fatty acids by deesterification due to the metabolism of bacteria indigenous to the skin, and then unsaturated fatty acids such as oleic acid and palmitoleic acid are further converted into odorants by oxidative decomposition reactions.
各透明皮膚洗浄剤組成物をその濃度が5質量%、臭気原因物質であるトリグリセライドが3質量%、精製水が93質量%で調製し、と30分間室温で撹拌した。その後30分間静置し、可溶化されている下層を抜き取り、トリグリセライドの取り込み量をHPLC(高速液体クロマトグラフ)を用いて測定した。 Each transparent skin cleanser composition was prepared with a concentration of 5% by mass, 3% by mass of triglyceride, which is an odor-causing substance, and 93% by mass of purified water, and stirred at room temperature for 30 minutes. After standing still for 30 minutes, the solubilized lower layer was extracted, and the amount of triglyceride uptake was measured using HPLC (high performance liquid chromatograph).
<分析条件>
装置:Waters Alliance
カラム:CAPCELLPAK C18 MG(4.6×150mm, 5μm)
移動相:A アセトニトリル、B イソプロパノール
Time(min) A B
0 50 50
15 20 80
温度:40℃
注入量:20μL
流速:1mL/分
検出器:フォトダイオードアレイ (PDA)、波長200~400(210.2nm)
<Analysis conditions>
Equipment: Waters Alliance
Column: CAPCELLPAK C18 MG (4.6×150mm, 5μm)
Mobile phase: A acetonitrile, B isopropanol
Time (min) A B
0 50 50
15 20 80
Temperature: 40°C
Injection volume: 20 μL
Flow rate: 1 mL/min Detector: Photodiode array (PDA), wavelength 200-400 (210.2 nm)
つぎに、得られた分析結果から、下記の評価基準に従って評価した。判断基準は以下の通りである。
◎:トリグリセライドの取り込み量(定量値)が、0.04%以上
○:トリグリセライドの取り込み量(定量値)が、0.025%以上0.04%未満
△:トリグリセライドの取り込み量(定量値)が、0.01%以上0.025%未満
×:トリグリセライドの取り込み量(定量値)が、0.01%未満
Next, from the obtained analysis results, evaluation was made according to the following evaluation criteria. Judgment criteria are as follows.
◎: triglyceride uptake (quantitative value) is 0.04% or more ○: triglyceride uptake (quantitative value) is 0.025% or more and less than 0.04% △: triglyceride uptake (quantitative value) is , 0.01% or more and less than 0.025% ×: triglyceride uptake amount (quantitative value) is less than 0.01%
実施例1~13及び比較例1~11
表1、2に示す組成のボディシャンプー組成物を調製し、これらを使用したときの起泡性、泡質(クリーミィ性)、すすぎ時のさっぱり感、低温安定性(外観)、皮脂汚れ洗浄効果について調べ、その結果を表1、2に示した。なお、以下の全ての実施例及び比較例における配合量は全て質量%である。
Examples 1-13 and Comparative Examples 1-11
Body shampoo compositions having the compositions shown in Tables 1 and 2 were prepared, and foamability, foam quality (creamy), refreshing feeling during rinsing, low-temperature stability (appearance), and sebum stain-cleansing effect when these were used. was investigated, and the results are shown in Tables 1 and 2. In addition, all compounding amounts in the following examples and comparative examples are in mass%.
表1、2より明らかなように、本発明の成分を用いた実施例1~13のボディシャンプ
ー組成物は、比較例1~11の組成物に比べていずれも優れた性能を見出した。
As is clear from Tables 1 and 2, the body shampoo compositions of Examples 1-13 using the components of the present invention were all found to have superior performance compared to the compositions of Comparative Examples 1-11.
以下、本発明の透明皮膚洗浄剤組成物のその他の処方例を挙げる。なお、これらの処方例の皮膚洗浄剤組成物についても、上記の起泡性、泡質(クリーミィ性)、すすぎ時のさっぱり感、低温安定性(外観)、皮脂汚れ洗浄効果の各項目を検討した。 Other formulation examples of the transparent skin cleanser composition of the present invention are given below. For the skin cleanser compositions of these formulation examples, the above-mentioned foamability, foam quality (creaminess), refreshing feeling during rinsing, low-temperature stability (appearance), and sebum stain cleansing effect were examined. bottom.
処方例1 ボディシャンプー
(1)ラウリン酸カリウム 8.0(2)ミリスチン酸カリウム 5.0(3)パルミチン酸カリウム 3.0(4)ステアリン酸カリウム 0.5(5)セテス-15 0.5(6)べへネス-20 0.1(7)オレス-20 0.5(8)ステアレス-20 0.1(9)ラウリルヒドロキシスルホベタイン 2.0(10)ヤシ油脂肪酸アミドプロピルベタイン 0.5(11)グリセリン 1.0(12)グリコシルトレハロース 0.5(13)ポリオキシエチレンラウリルエーテル硫酸ナトリウム 1.5(14)ヤシ油脂肪酸モノエタノールアミド 3.0(15)ステアリン酸PEG-25 0.1(16)ヒドロキシプロピルメチルセルロース 0.4(17)塩化ジメチルジアリルアンモニウム・アクリルアミド共重合体 0.3(18)シクロヘキサン-1,4-ジカルボン酸ビスエトキシジグリコール 0.1(19)l-メントール 0.1(20)ハッカ油 0.1(21)チャ葉エキス 0.5(22)カキタンニン 0.01(23)サピンヅストリホリアツス果実エキス 0.01(24)イソプロピルメチルフェノール 0.1(25)エデト酸二ナトリウム 0.2(26)香料 0.7(27)精製水 残 余
(pH 10.2)
Formulation Example 1 Body Shampoo (1) Potassium Laurate 8.0 (2) Potassium Myristate 5.0 (3) Potassium Palmitate 3.0 (4) Potassium Stearate 0.5 (5) Ceteth-15 0.5 (6) Beheneth-20 0.1 (7) Oleth-20 0.5 (8) Steareth-20 0.1 (9) Lauryl hydroxysulfobetaine 2.0 (10) Coconut fatty acid amidopropyl betaine 0. 5 (11) glycerin 1.0 (12) glycosyl trehalose 0.5 (13) sodium polyoxyethylene lauryl ether sulfate 1.5 (14) coconut oil fatty acid monoethanolamide 3.0 (15) PEG-25 stearate 0 .1 (16) hydroxypropyl methylcellulose 0.4 (17) dimethyldiallylammonium chloride/acrylamide copolymer 0.3 (18) cyclohexane-1,4-dicarboxylic acid bisethoxydiglycol 0.1 (19) l-menthol 0.1 (20) Mentha oil 0.1 (21) Tea leaf extract 0.5 (22) Oyster tannin 0.01 (23) Sapindus trifoliatus fruit extract 0.01 (24) Isopropylmethylphenol 0.1 (25) Disodium edetate 0.2 (26) Perfume 0.7 (27) Purified water Remainder (pH 10.2)
常法により上記組成のボディシャンプーを調製し、起泡性、泡質(クリーミィ性)、すすぎ時のさっぱり感、低温安定性(外観)、皮脂汚れ洗浄効果を評価したところ、いずれの特性も優れており良好な結果(◎又は〇)を得た。 A body shampoo having the above composition was prepared by a conventional method and evaluated for foamability, foam quality (creaminess), refreshing feeling when rinsing, low temperature stability (appearance), and sebum stain cleansing effect. Good results (◎ or 〇) were obtained.
処方例2 泡吐出型ボディシャンプー
(1)ラウリン酸カリウム 3.0(2)ミリスチン酸カリウム 1.0(3)セテス-15 0.5(4)べへネス-20 0.1(5)オレス-20 0.5(6)ステアレス-20 0.1(7)ヤシ油アルキルジメチルアミノ酢酸ベタイン 2.0(8)ラウリン酸アミドプロピルベタイン 2.0(9)グリセリン 1.0
(10)DPG 3.0(11)ラウレス-100 2.5(12)ステアリン酸PEG-25 0.1(13)シクロヘキサン-1,4-ジカルボン酸ビスエトキシジグリコール 0.1(14)l-メントール 0.1(15)サトウキビエキス 0.1(16)オウゴン根エキス 0.1(17)シャクヤク根エキス 0.1(18)イソプロピルメチルフェノール 0.1(19)フェノキシエタノール 0.5(20)エデト酸二ナトリウム 0.2(21)香料 0.4(22)精製水 残 余
(pH 9.7)
Formulation Example 2 Foaming Body Shampoo (1) Potassium Laurate 3.0 (2) Potassium Myristate 1.0 (3) Ceteth-15 0.5 (4) Beheneth-20 0.1 (5) Oleth -20 0.5 (6) Steareth-20 0.1 (7) Coconut oil alkyldimethylaminoacetic acid betaine 2.0 (8) Lauramidopropyl betaine 2.0 (9) Glycerin 1.0
(10) DPG 3.0 (11) Laureth-100 2.5 (12) PEG-25 stearate 0.1 (13) Cyclohexane-1,4-dicarboxylic acid bisethoxydiglycol 0.1 (14) l- Menthol 0.1 (15) Sugar cane extract 0.1 (16) Scutellaria root extract 0.1 (17) Peony root extract 0.1 (18) Isopropylmethylphenol 0.1 (19) Phenoxyethanol 0.5 (20) Edet Disodium acid acid 0.2 (21) Perfume 0.4 (22) Purified water Balance (pH 9.7)
常法により上記組成のボディシャンプーを調製し、起泡性、泡質(クリーミィ性)、すすぎ時のさっぱり感、低温安定性(外観)、皮脂汚れ洗浄効果を評価したところ、いずれの特性も優れており良好な結果(◎又は〇)を得た。
A body shampoo having the above composition was prepared by a conventional method and evaluated for foamability, foam quality (creaminess), refreshing feeling when rinsing, low temperature stability (appearance), and sebum stain cleansing effect. Good results (◎ or 〇) were obtained.
Claims (2)
(A)高級脂肪酸塩
(B)HLB値が13~18であるポリオキシエチレンアルキルエーテル
(C)アミノ酢酸ベタイン型両性界面活性剤又はスルホベタイン型両性界面活性剤 A transparent skin cleanser composition comprising the following components (A) to (C) and having a pH of 9 to 11.
(A) Higher fatty acid salt (B) Polyoxyethylene alkyl ether having an HLB value of 13 to 18 (C) Aminoacetic acid betaine type amphoteric surfactant or sulfobetaine type amphoteric surfactant
2. The transparent skin cleanser composition according to claim 1, wherein said component (B) accounts for 0.05 to 5% of the total weight.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021127502A JP2023022566A (en) | 2021-08-03 | 2021-08-03 | Transparent skin cleansing composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021127502A JP2023022566A (en) | 2021-08-03 | 2021-08-03 | Transparent skin cleansing composition |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2023022566A true JP2023022566A (en) | 2023-02-15 |
Family
ID=85201693
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021127502A Pending JP2023022566A (en) | 2021-08-03 | 2021-08-03 | Transparent skin cleansing composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2023022566A (en) |
-
2021
- 2021-08-03 JP JP2021127502A patent/JP2023022566A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2016323835B2 (en) | Compositions comprising zwitterionic alkyl-alkanoylamides and/or alkyl alkanoates | |
JP6183849B2 (en) | Skin cleanser composition | |
JP6134837B1 (en) | Liquid detergent composition | |
JP2013163659A (en) | Skin detergent composition | |
JP2014125435A (en) | Skin cleanser composition | |
JP6062279B2 (en) | Liquid detergent composition | |
JP2013163658A (en) | Skin detergent composition | |
JP6812099B2 (en) | Skin cleanser | |
JP2014156538A (en) | Liquid detergent composition | |
JP7217925B2 (en) | skin cleanser composition | |
JP6029973B2 (en) | Skin cleanser composition | |
JP2016094375A (en) | Liquid detergent composition for foamer container | |
JP2012149198A (en) | Skin detergent composition | |
JP2014129244A (en) | Skin cleanser composition | |
JP6990496B2 (en) | Detergent composition | |
JP2023022566A (en) | Transparent skin cleansing composition | |
JP7326728B2 (en) | solid soap composition | |
JP7204162B2 (en) | detergent composition | |
CN112449593A (en) | Skin cleanser composition | |
JP6619423B2 (en) | Cleaning fee | |
JP2020040903A (en) | Detergent composition | |
JP2016124828A (en) | Improving agent, preventing agent, and detergent composition for senile xerosis | |
JP2022061049A (en) | Skin cleansing composition | |
JP6366437B2 (en) | Skin cleanser composition | |
JP2023027812A (en) | skin cleanser composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20240325 |